GV

Ben Robbins, general partner at GV, wraps up MobiHealthNews' investment series by unveiling the crucial traits digital health companies must possess to secure funding in a highly competitive market.

Brightline has now secured nearly $100 million in funding to date.  

Coming in six months after its $26 million Series A round, Headway now boasts $103 million in total funding and a new valuation of $750 million.   

New investor GV led the round, with participation from existing investors  Jerusalem Venture Partners, Upfront Ventures, RRE Ventures and Rho Capital Partners.   

Andreessen Horowitz, F-Prime Capital, GV, and Transformation Capital led the round with participation from existing investors. 

The new funding round was led by GV with participation from Bain Capital Ventures, Casdin Capital and Define Ventures. 

The company plans on using the new funds to expand its services to new locations. 

The Series B round was led by Greenoaks with participation from Threshold Ventures, CRV, GV and Kleiner Perkins. 

The Pill Club, a company that provides telemedicine and mail-order pharmacy services to help women access birth control, has raised $51 million in Series B funding, bringing its total funding up to $67 million.

Tele-ophthalmology company DigiSight — now called Verana Health — has a new name, a new mission, a new CEO, and $30 million dollars in new funding led by Alphabet subsidiary GV (formerly Google Ventures).